Generic Semaglutide Distribution and Patient Management Network

The Opportunity

Semaglutide just went off patent, flooding the market with generics at 50-80% lower cost (₹3,000/month vs ₹12,000/month). But this sudden price drop means millions of Indians — young people wanting weight loss, middle-class diabetics, and tier-2 city residents — now have access to a drug they couldn't afford before. However, there's no organized distribution network, patient education system, or doctor-pharmacy coordination to handle this surge safely. People will buy these generics from anywhere, often without proper medical monitoring or side-effect awareness.